Zai Lab Ltd (NAS:ZLAB)
$ 20.16 0.15 (0.75%) Market Cap: 1.98 Bil Enterprise Value: 1.42 Bil PE Ratio: 0 PB Ratio: 2.57 GF Score: 71/100

Zai Lab Ltd at JPMorgan Healthcare Conference Transcript

Jan 10, 2023 / 05:00PM GMT
Release Date Price: $42.26 (+0.26%)
Anupam Rama
JPMorgan Chase & Co, Research Division - VP and Analyst

Thanks, everyone. Welcome to Tuesday morning of the 41st Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by Malcolm Kuno, and Priyanka Grover from the team. Our next presenting company is Zai Lab and presenting on behalf of the company, we have the CEO, Samantha Du. Samantha?

Ying Du
Zai Lab Limited - Founder, Chairperson & CEO

Thank you, Anupam. Good morning, everyone. It's such a great pleasure to be with you here today. Slide #2 is the safe harbor slide. I'll skip to just Slide #3, please. Zai Lab was founded 14 years ago with ambition to bring first or best-in-class assets to patients first in China, than around the world. Over the last [3] years, we have a -- really the team worked very hard and to seize this once in the [nutrition] opportunity as a biopharma leader in China through dedication, hard work, OS, like R&D, BD commercial team. So I'm here to want to thank my team for what you have

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot